---
title: "Sangam Health Care Products (SANHP) Financials & Shareholding"
symbol: "531625"
company: "Sangam Health Care Products Ltd"
canonical: "https://tapetide.com/stocks/531625"
isin: "INE431E01011"
bse_code: "531625"
sector: "Healthcare"
industry: "Healthcare Equipment & Supplies"
generated_at: "2026-11-05T01:41:08.590Z"
---

# Sangam Health Care Products (SANHP)

Canonical page: https://tapetide.com/stocks/531625

## Key Facts

- **Revenue, Jun 2026 quarter:** ₹3.03 Cr, against ₹2.82 Cr in Jun 2025 (+7.45% year on year)
- **Net profit, Jun 2026 quarter:** ₹0.31 Cr, against ₹0.10 Cr in Jun 2025
- **Promoter holding:** 70.12% in Jun 2026, unchanged from Mar 2026

## Company

- **BSE code:** 531625
- **ISIN:** INE431E01011
- **Macro sector:** Healthcare
- **Sector:** Healthcare
- **Industry:** Healthcare Equipment & Supplies
- **Basic industry:** Medical Equipment & Supplies
- **In the F&O segment:** No

## Key Insights

### Weaknesses

- The company has delivered a poor sales growth of 3.32% over past five years.
- Debtor days have increased from 76.2 to 114 days.

## Growth Rate

Growth computed from the financial statements below. A window with no rate gives the reason instead of a figure.

| Metric | Window | Growth | What it compares |
| --- | --- | ---: | --- |
| Revenue | 10Y | -7.2% | compounded annual rate, Mar 2016 to Mar 2026 |
| Revenue | 5Y | 3.32% | compounded annual rate, Mar 2021 to Mar 2026 |
| Revenue | 3Y | 1.44% | compounded annual rate, Mar 2023 to Mar 2026 |
| Revenue | 1Y | -9.87% | fiscal year to Mar 2026 vs the year to Mar 2025 |
| Revenue | TTM | -3.7% | four quarters to Jun 2026 vs the four to Jun 2025 |
| Net profit | 10Y | Turned to profit | compounded annual rate, Mar 2016 to Mar 2026: -₹1.54 Cr to ₹0.05 Cr. A loss at the start and a profit at the end. A growth rate off a loss has no meaning. |
| Net profit | 5Y | Turned to profit | compounded annual rate, Mar 2021 to Mar 2026: -₹2.30 Cr to ₹0.05 Cr. A loss at the start and a profit at the end. A growth rate off a loss has no meaning. |
| Net profit | 3Y | Turned to profit | compounded annual rate, Mar 2023 to Mar 2026: -₹1.16 Cr to ₹0.05 Cr. A loss at the start and a profit at the end. A growth rate off a loss has no meaning. |
| Net profit | 1Y | -88.89% | fiscal year to Mar 2026 vs the year to Mar 2025 |
| Net profit | TTM | -2.13% | four quarters to Jun 2026 vs the four to Jun 2025 |
| Operating cash flow | 10Y | Turned positive | compounded annual rate, Mar 2016 to Mar 2026: -₹0.37 Cr to ₹0.03 Cr. A cash outflow at the start and an inflow at the end. |
| Operating cash flow | 5Y | -26.52% | compounded annual rate, Mar 2021 to Mar 2026 |
| Operating cash flow | 3Y | -77.08% | compounded annual rate, Mar 2023 to Mar 2026 |
| Operating cash flow | 1Y | Turned positive | fiscal year to Mar 2026 vs the year to Mar 2025: -₹2.76 Cr to ₹0.03 Cr. A cash outflow at the start and an inflow at the end. |
| Operating cash flow | TTM | — | four quarters to Jun 2026 vs the four to Jun 2025. Reported once a year, so there is no trailing-twelve-month figure. |
| Operating margin | 10Y | -12.62 pp | compounded annual rate, Mar 2016 to Mar 2026 |
| Operating margin | 5Y | +16.07 pp | compounded annual rate, Mar 2021 to Mar 2026 |
| Operating margin | 3Y | +3.35 pp | compounded annual rate, Mar 2023 to Mar 2026 |
| Operating margin | 1Y | -9.49 pp | fiscal year to Mar 2026 vs the year to Mar 2025 |
| Operating margin | TTM | -5.20 pp | four quarters to Jun 2026 vs the four to Jun 2025 |

## Financial Statements

### Quarterly Results

Figures in ₹ crore unless the row name gives another unit.

| Item | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Sales | 2.56 | 3.05 | 3.53 | 2.97 | 3.39 | 3.62 | 2.87 | 2.58 | 2.82 | 3.04 | 2.72 | 2.66 | 3.03 |
| Expenses | 2.94 | 2.54 | 2.66 | 2.79 | 3 | 3.24 | 2.46 | 2.29 | 2.7 | 2.74 | 2.42 | 3.14 | 2.59 |
| Operating Profit | -0.38 | 0.51 | 0.87 | 0.18 | 0.39 | 0.38 | 0.41 | 0.29 | 0.12 | 0.3 | 0.3 | -0.48 | 0.44 |
| OPM % | -14.84% | 16.72% | 24.65% | 6.06% | 11.5% | 10.5% | 14.29% | 11.24% | 4.26% | 9.87% | 11.03% | -18.05% | 14.52% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0.02 | 0 |
| Interest | 0.01 | 0 | 0.01 | 0.01 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.3 | 0.3 | 0.3 | 0.31 | 0.3 | 0.3 | 0.3 | 0.31 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
| Profit before tax | -0.69 | 0.21 | 0.56 | -0.14 | 0.09 | 0.08 | 0.11 | -0.01 | 0.11 | 0.29 | 0.29 | -0.48 | 0.43 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -1,900% | 9.09% | 17.24% | 34.48% | -39.58% | 27.91% |
| Net Profit | -0.69 | 0.2 | 0.56 | -0.14 | 0.08 | 0.07 | 0.11 | 0.19 | 0.1 | 0.23 | 0.2 | -0.28 | 0.31 |
| EPS in Rs | -0.46 | 0.13 | 0.38 | -0.09 | 0.05 | 0.05 | 0.07 | 0.13 | 0.07 | 0.15 | 0.13 | -0.19 | 0.21 |

### Profit & Loss

Figures in ₹ crore unless the row name gives another unit.

| Item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Sales | 25.44 | 23.71 | 24.16 | 20.99 | 21.04 | 21.81 | 9.54 | 8.7 | 10.76 | 12.11 | 12.46 | 11.23 | 11.45 |
| Expenses | 21.43 | 20.19 | 24.55 | 25.62 | 20.09 | 19.78 | 10.86 | 9.1 | 10.88 | 10.67 | 11 | 10.98 | 10.89 |
| Operating Profit | 4.01 | 3.52 | -0.39 | -4.63 | 0.95 | 2.03 | -1.32 | -0.4 | -0.12 | 1.44 | 1.46 | 0.25 | 0.56 |
| OPM % | 15.76% | 14.85% | -1.61% | -22.06% | 4.52% | 9.31% | -13.84% | -4.6% | -1.12% | 11.89% | 11.72% | 2.23% | 4.89% |
| Other Income | 4.75 | 0.27 | 0.12 | 18.41 | 0.47 | 2.93 | 0.02 | 0 | 0 | 0 | 0.02 | 0.02 | 0.02 |
| Interest | 5.46 | 3.8 | 5.05 | 3.33 | 2.1 | 0.29 | 0.07 | 0.11 | 0.03 | 0.02 | 0.01 | 0.01 | 0 |
| Depreciation | 1.51 | 1.53 | 1.52 | 1.52 | 1.5 | 1.26 | 1.22 | 1.22 | 1.22 | 1.22 | 1.22 | 0.06 | 0.05 |
| Profit before tax | 1.79 | -1.54 | -6.84 | 8.93 | -2.18 | 3.41 | -2.59 | -1.73 | -1.37 | 0.2 | 0.25 | 0.2 | 0.53 |
| Tax % | 0% | 0% | 0.29% | 17.36% | -6.88% | -18.77% | -11.2% | -10.4% | -14.6% | -110% | -76% | 75% | — |
| Net Profit | 1.79 | -1.54 | -6.86 | 7.37 | -2.03 | 4.05 | -2.3 | -1.55 | -1.16 | 0.42 | 0.45 | 0.05 | 0.46 |
| EPS in Rs | 1.2 | -1.04 | -4.62 | 4.96 | -1.37 | 2.73 | -1.55 | -1.04 | -0.78 | 0.28 | 0.3 | 0.03 | 0.3 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |

### Balance Sheet

Figures in ₹ crore unless the row name gives another unit.

| Item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Equity Capital | 14.86 | 14.86 | 14.86 | 14.86 | 14.86 | 14.86 | 14.86 | 14.86 | 14.86 | 14.86 | 14.86 | 14.86 |
| Reserves | -31.81 | -33.35 | -37.85 | -28.59 | -34.83 | -30.78 | -33.08 | -34.63 | -35.79 | -35.37 | -34.92 | -34.71 |
| Borrowings | 35.37 | 36.08 | 37.27 | 17.25 | 21.15 | 17.59 | 18.21 | 23.4 | 21.08 | 19.34 | 21.98 | 21.93 |
| Other Liabilities | 14.15 | 15.13 | 13.65 | 18.66 | 22.59 | 11.29 | 9.43 | 5.46 | 7.92 | 7.67 | 9.42 | 9.14 |
| Total Liabilities | 32.57 | 32.72 | 27.93 | 22.18 | 23.77 | 12.96 | 9.42 | 9.09 | 8.07 | 6.5 | 11.34 | 11.22 |
| Fixed Assets | 23.94 | 22.63 | 21.44 | 19.93 | 18.65 | 6.24 | 5.02 | 3.81 | 2.61 | 1.39 | 0.18 | 0.3 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 8.63 | 10.09 | 6.49 | 2.25 | 5.12 | 6.72 | 4.4 | 5.28 | 5.46 | 5.11 | 11.16 | 10.92 |
| Total Assets | 32.57 | 32.72 | 27.93 | 22.18 | 23.77 | 12.96 | 9.42 | 9.09 | 8.07 | 6.5 | 11.34 | 11.22 |

### Cash Flow

Figures in ₹ crore unless the row name gives another unit.

| Item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash from Operating Activity | -16.8 | -0.37 | -4.44 | -5.97 | 11.05 | -11.08 | 0.14 | 0.99 | 2.49 | 1.94 | -2.76 | 0.03 |
| Cash from Investing Activity | 4.71 | -0.21 | -0.29 | 18.7 | -1.02 | 11.18 | 0.02 | 0.02 | 0 | 0 | 0 | -0.02 |
| Cash from Financing Activity | 12.22 | 2.07 | 3.13 | -12.72 | -10.15 | -0.02 | -0.13 | -0.13 | -2.35 | -1.77 | 2.63 | -0.06 |
| Net Cash Flow | 0.13 | 1.48 | -1.6 | 0.01 | -0.12 | 0.07 | 0.03 | 0.88 | 0.14 | 0.18 | -0.13 | -0.06 |
| Free Cash Flow | -16.84 | -0.58 | -4.78 | -5.98 | 10.82 | 0.08 | 0.14 | 0.99 | 2.49 | 1.94 | -2.76 | 0.03 |
| CFO/OP | -419 | -11 | 1,138 | 129 | 1,171 | -546 | -11 | -248 | -2,075 | 135 | -189 | 12 |

### Ratios

| Item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Debtor Days | 3.73 | 2 | 0.91 | 0.17 | 6.07 | 8.37 | 26.4 | 25.59 | 21.37 | 8.14 | 106 | 114 |
| Inventory Days | 327 | 257 | 136 | 21.81 | 107 | 137 | 68.48 | 133 | 162 | 101 | 90.56 | 78.77 |
| Days Payable | 259 | 286 | 156 | 127 | 155 | 219 | 285 | 191 | 384 | 359 | 455 | 480 |
| Cash Conversion Cycle | 71.32 | -26.94 | -19.07 | -106 | -41.64 | -73.53 | -190 | -32.73 | -201 | -250 | -258 | -286 |
| Working Capital Days | -225 | -240 | -254 | -339 | -628 | -346 | -880 | -981 | -107 | -110 | -77.92 | -75.41 |
| ROCE % | 37.12% | 12.55% | -11.23% | 137.75% | -3.4% | 259.65% | -303.61% | -89.5% | -70.9% | — | 69.33% | 10.5% |

## Shareholding Pattern

### Quarterly Shareholding

Holdings in % of shares; shareholders as a count.

| Holder | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Promoters | 70.12% | 70.12% | 70.12% | 70.12% | 70.12% | 70.12% | 70.12% | 70.12% | 70.12% | 70.12% | 70.12% | 70.12% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DIIs | 8.43% | 8.43% | 8.43% | 8.43% | 8.43% | 8.43% | 8.43% | 8.43% | 8.43% | 8.43% | 8.43% | 8.43% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 21.44% | 21.44% | 21.44% | 21.44% | 21.44% | 21.44% | 21.44% | 21.44% | 21.44% | 21.44% | 21.44% | 21.44% |
| Others | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| No. of Shareholders | 640 | 640 | 640 | 640 | 640 | 640 | 640 | 640 | 640 | 640 | 640 | 640 |

### Annual Shareholding

Holdings in % of shares; shareholders as a count.

| Holder | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Jun 2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Promoters | 70.12% | 70.12% | 70.12% | 70.12% | 70.12% | 70.12% | 70.12% | 70.12% | 70.12% | 70.12% | 70.12% | 70.12% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DIIs | 8.43% | 8.43% | 8.43% | 8.43% | 8.43% | 8.43% | 8.43% | 8.43% | 8.43% | 8.43% | 8.43% | 8.43% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 21.44% | 21.44% | 21.44% | 21.44% | 21.44% | 21.44% | 21.44% | 21.44% | 21.44% | 21.44% | 21.44% | 21.44% |
| Others | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| No. of Shareholders | 648 | 635 | 635 | 635 | 637 | 637 | 640 | 640 | 640 | 640 | 640 | 640 |

## Documents

### Credit ratings

| Date | Document |
| --- | --- |
| 21 Nov 2025 | [Credit rating update — CRISIL](https://www.crisil.com/mnt/winshare/Ratings/RatingList/RatingDocs/SangamHealthCareProductsLimited_November%2021_%202025_RR_380742.html) |
| 30 Aug 2024 | [Credit rating update — CRISIL](https://www.crisil.com/mnt/winshare/Ratings/RatingList/RatingDocs/SangamHealthCareProductsLimited_August%2030_%202024_RR_351563.html) |
| 30 Jun 2023 | [Credit rating update — CRISIL](https://www.crisil.com/mnt/winshare/Ratings/RatingList/RatingDocs/SangamHealthCareProductsLimited_June%2030,%202023_RR_322381.html) |
| 30 Apr 2022 | [Credit rating update — CRISIL](https://www.crisil.com/mnt/winshare/Ratings/RatingList/RatingDocs/SangamHealthCareProductsLimited_April%2030,%202022_RR_292604.html) |
| 27 Feb 2021 | [Credit rating update — CRISIL](https://www.crisil.com/mnt/winshare/Ratings/RatingList/RatingDocs/SangamHealthCareProductsLimited_February%2027,%202021_RR_265235.html) |
| 28 Nov 2019 | [Credit rating update — CRISIL](https://www.crisil.com/mnt/winshare/Ratings/RatingList/RatingDocs/Sangam_Health_Care_Products_Limited_November_28_2019_RR.html) |

### Exchange filings

Latest 12 of 27.

| Date | Document | Category |
| --- | --- | --- |
| 13 Oct 2026 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7ddcd12-4948-48e3-aa7b-8183f9a16b26.pdf) | General announcements |
| 12 Oct 2026 | [Board Meeting Outcome for Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2631609-8398-48d9-a135-12899801400b.pdf) | Outcome |
| 12 Oct 2026 | [Appointment of Company Secretary and Compliance Officer](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8af62d4-811b-41ee-90ac-40ead7a12286.pdf) | General announcements |
| 30 Sep 2026 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa9c9fc8-fa1f-47a3-9523-32d78df6e736.pdf) | Outcome |
| 30 Sep 2026 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6a06bf3-d89b-48b5-af8f-e1c94efa6b57.pdf) | Outcome |
| 28 Sep 2026 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13338ed5-c5ee-471f-9db7-a46e93c0e249.pdf) | Intimation |
| 11 Sep 2026 | [Compliances-Reg.24(A)-Annual Secretarial Compliance](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a72de7c3-b9df-478f-8d42-f4b60eceee37.pdf) | Compliance |
| 9 Sep 2026 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb11ad1b-eaec-40e0-b112-eb70e962bd91.pdf) | General announcements |
| 9 Sep 2026 | [Notice Of Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cf5e3f8-9c29-4338-962b-d5f114ff3e6b.pdf) | Intimation |
| 9 Sep 2026 | [Intimation Of Book Closure](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af4bcd55-2444-49c7-8ddb-5237f30d4c68.pdf) | General announcements |
| 8 Sep 2026 | [Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68893602-415a-4a59-8c32-2e99f6c7f52a.pdf) | General announcements |
| 13 Aug 2026 | [Financial Results Fort The Quarter Ended 30.06.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3bb1a006-fbaa-41f4-86f2-07f05bc25276.pdf) | Outcome |

## Frequently Asked Questions about Sangam Health Care Products

### What does Sangam Health Care Products Ltd do?

Sangam Health Care Products is engaged manufacturing and trading of medical products

### Where is Sangam Health Care Products Ltd (SANHP) listed?

Sangam Health Care Products Ltd trades under code 531625 on the BSE.

### Which sector does Sangam Health Care Products Ltd belong to?

Sangam Health Care Products Ltd is classified under the Healthcare sector, in the Healthcare Equipment & Supplies industry.

## Company Information

Sangam Health Care Products is engaged manufacturing and trading of medical products

- **Face Value:** ₹10

---

Negative figures use an ASCII hyphen-minus (-) so they parse as numbers. Amounts are in Indian rupees; "Cr" is crore (10 million). Dates are Indian Standard Time.

Financial statements, shareholding and filings are as reported by the company. Price, volume and 52-week levels are market data. Technical indicators are computed by Tapetide from daily prices. The Tapetide Score is Tapetide’s own analysis. Analyst ratings and forecasts are the published estimates of third-party analysts, not company statements. The AI sections are generated text.

For research and information only, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Generated 5 Nov 2026, 07:11 IST.